<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="006646-2018"
            EDITION="2018005">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-007222-001</RECEPTION_ID>
      <DELETION_DATE>20180205</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>5</NO_OJ>
         <DATE_PUB>20180109</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 005-006646</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:006646-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>http://www.achatpublic.com</IA_URL_GENERAL>
         <IA_URL_ETENDERING>http://www.achatpublic.com</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FRI33">Deux-Sèvres</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FRI33">Deux-Sèvres</n2016:CA_CE_NUTS>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180105</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180205</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B02</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Niort</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">Centre Hospitalier de Niort</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Centre Hospitalier de Niort</OFFICIALNAME>
               <ADDRESS>40 avenue Charles de Gaulle</ADDRESS>
               <TOWN>Niort Cedex</TOWN>
               <POSTAL_CODE>79021</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <E_MAIL>vera.jean@ch-niort.fr</E_MAIL>
               <n2016:NUTS CODE="FRI33"/>
               <URL_GENERAL>http://www.achatpublic.com</URL_GENERAL>
               <URL_BUYER>http://www.achatpublic.com</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>http://www.achatpublic.com</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>http://www.achatpublic.com</URL_PARTICIPATION>
            <ADDRESS_PARTICIPATION_IDEM/>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Fournitures de médicaments pour le groupement de commandes région Poitou Charentes Vendée</P>
            </TITLE>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Fournitures de médicaments pour le groupement de commandes région Poitou Charentes Vendée.</P>
            </SHORT_DESCR>
            <LOT_DIVISION>
               <LOT_ALL/>
            </LOT_DIVISION>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Inhibiteur de la Dpp-4 voie orale</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Inhibiteur de la Dpp-4 voie orale.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Bosentan voie orale</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Bosentan voie orale.</P>
                  <P>Atc C02 - aNTIHYPERTENSEURS.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Rilmenidine voie orale</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Rilmenidine voie orale.</P>
                  <P>Atc C02 - aNTIHYPERTENSEURS.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Rosuvastatine voie orale</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Rosuvastatine voie orale.</P>
                  <P>Atc C10 - hypolipidemiants.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>Glycerol vaseline paraffine 15 %/8 %/2 % CREME</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Glycerol vaseline paraffine 15 %/8 %/2 % Creme.</P>
                  <P>Atc D02 - emollients et protecteurs.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>Clarithromycine voie orale</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Clarithromycine voie orale.</P>
                  <P>Atc J01 - antibacteriens systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>Colistine 1 million ui injectable</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Colistine 1 million ui injectable.</P>
                  <P>Atc J01 - antibacteriens systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>Daptomycine injectable</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Daptomycine injectable.</P>
                  <P>Atc J01 - antibacteriens systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <TITLE>
                  <P>Erythromycine injectable</P>
               </TITLE>
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Erythromycine injectable.</P>
                  <P>Atc J01 - antibacteriens systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <TITLE>
                  <P>Piperacilline + tazobactam injectable</P>
               </TITLE>
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Piperacilline + tazobactam injectable.</P>
                  <P>Atc J01 - antibacteriens systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <TITLE>
                  <P>Emtricitabine + tenofovir + efavirenz voie orale</P>
               </TITLE>
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Emtricitabine + tenofovir + efavirenz voie orale.</P>
                  <P>Atc J05 - antiviraux systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <TITLE>
                  <P>Emtricitabine + tenofovir voie orale</P>
               </TITLE>
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Emtricitabine + tenofovir voie orale.</P>
                  <P>Atc J05 - antiviraux systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-03-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <TITLE>
                  <P>Ganciclovir 500 mg injectable</P>
               </TITLE>
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Ganciclovir 500 mg injectable.</P>
                  <P>Atc J05 - antiviraux systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-03-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <TITLE>
                  <P>Nevirapine lp 400 mg voie orale</P>
               </TITLE>
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Nevirapine lp 400 mg voie orale.</P>
                  <P>Atc J05 - antiviraux systemiques.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <TITLE>
                  <P>Doxorubicine injectable</P>
               </TITLE>
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Doxorubicine injectable.</P>
                  <P>Atc L01 - aNTINEOPLASIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="16">
               <TITLE>
                  <P>Imatinib voie orale</P>
               </TITLE>
               <LOT_NO>16</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Imatinib voie orale.</P>
                  <P>Atc L01 - aNTINEOPLASIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="17">
               <TITLE>
                  <P>Misoprostol voie orale: Indication interruption médicale grossesse intra-utérine</P>
               </TITLE>
               <LOT_NO>17</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Misoprostol voie orale: Indication interruption médicale grossesse intra-utérine.</P>
                  <P>Atc L01 - aNTINEOPLASIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="18">
               <TITLE>
                  <P>Mitoxantrone injectable</P>
               </TITLE>
               <LOT_NO>18</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Mitoxantrone injectable.</P>
                  <P>Atc L01 - aNTINEOPLASIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="19">
               <TITLE>
                  <P>Rituximab injectable</P>
               </TITLE>
               <LOT_NO>19</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Rituximab injectable.</P>
                  <P>Atc L01 - aNTINEOPLASIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="20">
               <TITLE>
                  <P>Oxycodone injectable</P>
               </TITLE>
               <LOT_NO>20</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Oxycodone injectable.</P>
                  <P>Atc N02 - aNALGESIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="21">
               <TITLE>
                  <P>Zonisamide voie orale</P>
               </TITLE>
               <LOT_NO>21</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Zonisamide voie orale.</P>
                  <P>Atc N03 - aNTI-EPILEPTIQUES.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="22">
               <TITLE>
                  <P>Rasagiline 1 mg voie orale</P>
               </TITLE>
               <LOT_NO>22</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRI33"/>
               <SHORT_DESCR>
                  <P>Rasagiline 1 mg voie orale.</P>
                  <P>Atc N04 - aNTI-PARKINSONIENS.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-03-05</DATE_START>
               <DATE_END>2018-12-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-02-05</DATE_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="FR"/>
            </LANGUAGES>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-02-05</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>14:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal administratif</OFFICIALNAME>
               <ADDRESS>15 rue de Blossac</ADDRESS>
               <TOWN>Poitiers</TOWN>
               <POSTAL_CODE>86000</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 549607919</PHONE>
               <FAX>+33 549606809</FAX>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>Les candidats pourront saisir le juge administratif: référé précontractuel (CJA, Art L. 551-1 et s) dans un délai de 11 jours à compter de la date d'envoi de la décision de ne pas retenir, référé contractuel (CJA, art L. 551-13 et s) dans un délai de 31 jours suivant les modalités d'accomplissement des publicités. Tous tiers au contrat peut introduire un recours en contestation de validité de contrat dans un délai de 2 mois suivant les modalités d'accomplissement de publicité.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-01-05</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
